U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 215833

PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN)
27mCi/ML
Marketing Status: Prescription
Active Ingredient: LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
Proprietary Name: PLUVICTO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 27mCi/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N215833
Product Number: 001
Approval Date: Mar 23, 2022
Applicant Holder Full Name: ADVANCED ACCELERATOR APPLICATIONS USA INC A NOVARTIS CO
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top